Thermo Scientific Stellar Mass Spectrometer
| Brand | Thermo Fisher |
|---|---|
| Origin | Shanghai, China |
| Manufacturer Type | Authorized Distributor |
| Origin Category | Domestic (China-made) |
| Model | Thermo Scientific Stellar |
| Pricing | Available Upon Request |
Overview
The Thermo Scientific Stellar Mass Spectrometer is a high-performance, targeted quantitative mass spectrometry platform engineered for seamless transition from biomarker discovery to clinical or regulatory validation. Built upon a hybrid quadrupole–Orbitrap architecture, the Stellar system leverages parallel reaction monitoring (PRM) and data-independent acquisition (DIA)-enabled targeted workflows to deliver exceptional specificity, sensitivity, and quantitative reproducibility across complex biological matrices. Unlike conventional triple quadrupole (QQQ) systems limited to scheduled MRM transitions, the Stellar integrates full-scan MSn acquisition with high-resolution, accurate-mass (HRAM) detection—enabling retrospective analysis of unanticipated analytes without re-injection. Its design prioritizes robustness in regulated environments, supporting method transfer between discovery and validation labs while maintaining compliance with ISO/IEC 17025, CLIA, and FDA 21 CFR Part 11 requirements for audit trails and electronic records.
Key Features
- Hybrid quadrupole–Orbitrap mass analyzer with up to 240,000 resolution (at m/z 200) and sub-ppm mass accuracy in external calibration mode
- Ultra-fast polarity switching (<50 ms) and duty-cycle-optimized scanning for comprehensive multi-analyte quantitation in single LC runs
- Advanced ion optics and vacuum architecture enabling sustained sensitivity down to low-attomole levels for peptides and small molecules
- Integrated SmartScan™ technology dynamically adjusts scan parameters in real time to maximize dwell time on target ions without compromising cycle time
- Rugged, modular design with field-replaceable ion sources (HESI, APCI, NanoFlex™) and automated calibration routines for minimal downtime
- Compliant with GLP/GMP-aligned instrument qualification protocols including IQ/OQ/PQ documentation templates
Sample Compatibility & Compliance
The Stellar MS supports diverse sample types—including plasma, serum, tissue homogenates, cell lysates, and biofluids—across proteomics, metabolomics, and pharmacokinetic applications. It accommodates standard 1–4.6 mm i.d. analytical columns and is fully compatible with nano-, micro-, and conventional-flow LC configurations. All hardware and firmware components meet CE marking requirements and conform to IEC 61010-1 safety standards. Data integrity features include secure user authentication, role-based access control, and immutable audit trails compliant with 21 CFR Part 11 and EU Annex 11. System suitability testing (SST) reports, peak area RSDs ≤8% over 24-h runs, and carryover <0.05% are routinely achievable under validated methods.
Software & Data Management
Controlled via Thermo Scientific Compound Discoverer 3.3 and TraceFinder 5.1 software suites, the Stellar platform enables end-to-end workflow automation—from raw data acquisition and spectral library matching to statistical analysis and report generation. TraceFinder’s embedded algorithm suite supports batch processing of PRM/DIA datasets with customizable integration windows, interference detection, and internal standard normalization. All raw files adhere to open mzML format; metadata tagging follows PSI-MIA standards. Integrated LIMS connectivity (via REST API or Thermo Scientific SampleManager) ensures traceability from sample receipt to final quantification report. Electronic signatures, version-controlled method storage, and automatic backup to network-attached storage (NAS) further reinforce data governance.
Applications
- Targeted biomarker verification in translational research cohorts (e.g., NCI Early Detection Research Network)
- Quantitative pharmacokinetic/pharmacodynamic (PK/PD) profiling of biologics and small-molecule therapeutics
- Regulatory submission support for FDA IND/BLA dossiers requiring HRAM-based quantitation
- Multi-omic integration studies linking proteoform-level changes with metabolite flux patterns
- High-throughput clinical assay development aligned with CAP-accredited laboratory standards
FAQ
Is the Stellar MS suitable for regulated bioanalysis under FDA or EMA guidelines?
Yes—the system supports full 21 CFR Part 11 and EU Annex 11 compliance when deployed with validated software configurations and documented instrument qualification.
Can existing QQQ-based SRM methods be migrated to the Stellar platform?
Absolutely—TraceFinder includes automated SRM-to-PRM conversion tools that preserve retention time alignment and optimize isolation windows for Orbitrap detection.
What level of technical support and service coverage is available globally?
Thermo Fisher provides factory-certified field service engineers, remote diagnostics, and multi-tier warranty options including Platinum Care Plans with guaranteed 4-hour response times.
Does the Stellar require liquid nitrogen or other cryogenic consumables?
No—it utilizes an all-electric, non-cryogenic Orbitrap analyzer, eliminating dependency on LN2 and reducing operational overhead.
How does the Stellar compare to legacy Q-TOF systems in targeted quantitation?
Unlike Q-TOF platforms, the Stellar delivers consistent sub-5% CVs at low-femtomolar concentrations due to its stable quadrupole front-end filtering and real-time centroiding algorithms optimized for PRM.
